[Uncommon lipodystrophic syndromes]

Med Clin (Barc). 2015 Jan 20;144(2):80-7. doi: 10.1016/j.medcli.2014.02.024. Epub 2014 Apr 29.
[Article in Spanish]
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acro-Osteolysis / pathology
  • Adipose Tissue / pathology
  • Aging, Premature / pathology
  • Body Composition
  • Cardiovascular System / pathology
  • Combined Modality Therapy
  • Diabetes Mellitus / drug therapy
  • Diet, Carbohydrate-Restricted
  • Diet, Fat-Restricted
  • Erythema Nodosum / pathology
  • Fingers / abnormalities
  • Fingers / pathology
  • Genes, Dominant
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Leptin / therapeutic use
  • Lipodystrophy* / classification
  • Lipodystrophy* / diagnosis
  • Lipodystrophy* / epidemiology
  • Lipodystrophy* / genetics
  • Lipodystrophy* / metabolism
  • Lipodystrophy* / pathology
  • Lipodystrophy* / therapy
  • Lipodystrophy, Familial Partial / diagnosis
  • Lipodystrophy, Familial Partial / genetics
  • Lipodystrophy, Familial Partial / pathology
  • Mandible / abnormalities
  • Mandible / pathology
  • Metformin / therapeutic use
  • Musculoskeletal Diseases / etiology
  • Phenotype
  • Recombinant Proteins / therapeutic use
  • Surgery, Plastic
  • Werner Syndrome / genetics
  • Werner Syndrome / pathology

Substances

  • Hypoglycemic Agents
  • Insulin
  • Leptin
  • Recombinant Proteins
  • Metformin

Supplementary concepts

  • Mandibuloacral dysplasia with type A lipodystrophy
  • Nakajo syndrome